Stable cell line development support for biologics programmes
Efficient CLD is critical in bringing biologics to market and requires a team of experienced scientists, a portfolio of well validated cell line platforms, and cell line development infrastructure and experienced scientific teams. Aragen had delivered over 200 cell lines to customers, including four commercial launches based on Aragen cell lines.
Support for a Broad Range of Host Cell Lines and Expression Vectors
Our R&D capabilities include proprietary DG44 cell line technology along with other advanced platforms such as (CHO GS). Our integrated offering, combined with expertise in complex biologics development enables us to address evolving customer requirements across modalities.
Experience in executing parallel processing and focused analytics to mitigate risks to client programs and shorten the timeline to IND, with scalable and reproducible processes.
